{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:58:27Z","timestamp":1795096707083,"version":"4.10.2"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20ek0109490h0001 and JP19ek0109285h0003"],"award-info":[{"award-number":["20ek0109490h0001 and JP19ek0109285h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1038\/s10038-022-01045-w","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T03:23:35Z","timestamp":1654572215000},"page":"215-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["A review of major causative genes in congenital myopathies"],"prefix":"10.1038","volume":"68","author":[{"given":"Masashi","family":"Ogasawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9452-112X","authenticated-orcid":false,"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"1045_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","volume":"14","author":"H Jungbluth","year":"2018","unstructured":"Jungbluth H, Treves S, Zorzato F, Sarkozy A, Ochala J, Sewry C, et al. Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction. Nat Rev Neurol. 2018;14:151\u201367.","journal-title":"Nat Rev Neurol"},{"key":"1045_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","volume":"24","author":"KN North","year":"2014","unstructured":"North KN, Wang CH, Clarke N, Jungbluth H, Vainzof M, Dowling JJ, et al. Approach to the diagnosis of congenital myopathies. Neuromuscul Disord. 2014;24:97\u2013116.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.spen.2019.01.004","volume":"29","author":"H Jungbluth","year":"2019","unstructured":"Jungbluth H, Muntoni F. Therapeutic aspects in congenital myopathies. Semin Pediatr Neurol. 2019;29:71\u201382.","journal-title":"Semin Pediatr Neurol"},{"key":"1045_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.nmd.2021.07.012","volume":"31","author":"J Laitila","year":"2021","unstructured":"Laitila J, Wallgren-Pettersson C. Recent advances in nemaline myopathy. Neuromuscul Disord. 2021;31:955\u201367.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR5","doi-asserted-by":"crossref","unstructured":"Saito Y, Nishikawa A, Iida A, Mori-Yoshimura M, Oya Y, Ishiyama A, et al. ADSSL1 myopathy is the most common nemaline myopathy in Japan with variable clinical features. Neurology. 2020;95:e1500-11.","DOI":"10.1212\/WNL.0000000000010237"},{"key":"1045_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/ene.13607","volume":"25","author":"Y Nilipour","year":"2018","unstructured":"Nilipour Y, Nafissi S, Tjust AE, Ravenscroft G, Hossein Nejad Nedai H, Taylor RL, et al. Ryanodine receptor type 3 (RYR3) as a novel gene associated with a myopathy with nemaline bodies. Eur J Neurol. 2018;25:841\u20137.","journal-title":"Eur J Neurol"},{"key":"1045_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10974-019-09519-9","volume":"40","author":"CA Sewry","year":"2019","unstructured":"Sewry CA, Laitila JM, Wallgren-Pettersson C. Nemaline myopathies: a current view. J Muscle Res Cell Motil. 2019;40:111\u201326.","journal-title":"J Muscle Res Cell Motil"},{"key":"1045_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1001\/jamaneurol.2015.37","volume":"72","author":"K Zukosky","year":"2015","unstructured":"Zukosky K, Meilleur K, Traynor BJ, Dastgir J, Medne L, Devoto M, et al. Association of a novel ACTA1 mutation with a dominant progressive scapuloperoneal myopathy in an extended family. JAMA Neurol. 2015;72:689\u201398.","journal-title":"JAMA Neurol"},{"key":"1045_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-012-1019-z","volume":"125","author":"KJ Nowak","year":"2013","unstructured":"Nowak KJ, Ravenscroft G, Laing NG. Skeletal muscle \u03b1-actin diseases (actinopathies): pathology and mechanisms. Acta Neuropathol. 2013;125:19\u201332.","journal-title":"Acta Neuropathol"},{"key":"1045_CR10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.nmd.2021.08.015","volume":"31","author":"M Ogasawara","year":"2021","unstructured":"Ogasawara M, Nishino I. A review of core myopathy: central core disease, multiminicore disease, dusty core disease, and core-rod myopathy. Neuromuscul Disord. 2021;31:968\u201377.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/brain\/86.4.793","volume":"86","author":"GM Shy","year":"1963","unstructured":"Shy GM, Engel WK, Somers JE, Wanko T. Nemaline myopathy. A new congenital myopathy. Brain. 1963;86:793\u2013810.","journal-title":"Brain"},{"key":"1045_CR12","first-page":"983","volume":"89","author":"PE Conen","year":"1963","unstructured":"Conen PE, Murphy EG, Donohue WL. Light and electron microscopic studies of \u201cmyogranules\u201d in a child with hypotonia and muscle weakness. Can Med Assoc J. 1963;89:983\u20136.","journal-title":"Can Med Assoc J"},{"key":"1045_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/2051-5960-2-44","volume":"2","author":"E Malfatti","year":"2014","unstructured":"Malfatti E, Lehtokari VL, B\u00f6hm J, De Winter JM, Sch\u00e4ffer U, Estournet B, et al. Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype. Acta Neuropathol Commun. 2014;2:44.","journal-title":"Acta Neuropathol Commun"},{"key":"1045_CR14","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1073\/pnas.96.5.2305","volume":"96","author":"K Pelin","year":"1999","unstructured":"Pelin K, Hilpel\u00e4 P, Donner K, Sewry C, Akkari PA, Wilton SD, et al. Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci USA. 1999;96:2305\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1045_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/13837","volume":"23","author":"KJ Nowak","year":"1999","unstructured":"Nowak KJ, Wattanasirichaigoon D, Goebel HH, Wilce M, Pelin K, Donner K, et al. Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet. 1999;23:208\u201312.","journal-title":"Nat Genet"},{"key":"1045_CR16","doi-asserted-by":"publisher","first-page":"e1425","DOI":"10.1212\/WNL.0000000000011458","volume":"96","author":"K Amburgey","year":"2021","unstructured":"Amburgey K, Acker M, Saeed S, Amin R, Beggs AH, B\u00f6nnemann CG, et al. A cross-sectional study of nemaline myopathy. Neurology. 2021;96:e1425\u201336.","journal-title":"Neurology"},{"key":"1045_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/cge.13745","volume":"97","author":"Q Wang","year":"2020","unstructured":"Wang Q, Hu Z, Chang X, Yu M, Xie Z, Lv H, et al. Mutational and clinical spectrum in a cohort of Chinese patients with hereditary nemaline myopathy. Clin Genet. 2020;97:878\u201389.","journal-title":"Clin Genet"},{"key":"1045_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1242\/jeb.126383","volume":"219","author":"M Chu","year":"2016","unstructured":"Chu M, Gregorio CC, Pappas CT. Nebulin, a multi-functional giant. J Exp Biol. 2016;219:146\u201352.","journal-title":"J Exp Biol"},{"key":"1045_CR19","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/humu.22693","volume":"35","author":"VL Lehtokari","year":"2014","unstructured":"Lehtokari VL, Kiiski K, Sandaradura SA, Laporte J, Repo P, Frey JA, et al. Mutation update: the spectra of nebulin variants and associated myopathies. Hum Mutat. 2014;35:1418\u201326.","journal-title":"Hum Mutat"},{"key":"1045_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nmd.2018.12.007","volume":"29","author":"KJ Kiiski","year":"2019","unstructured":"Kiiski KJ, Lehtokari VL, Vihola AK, Laitila JM, Huovinen S, Sagath LJ, et al. Dominantly inherited distal nemaline\/cap myopathy caused by a large deletion in the nebulin gene. Neuromuscul Disord. 2019;29:97\u2013107.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.nmd.2004.03.006","volume":"14","author":"C Wallgren-Pettersson","year":"2004","unstructured":"Wallgren-Pettersson C, Pelin K, Nowak KJ, Muntoni F, Romero NB, Goebel HH, et al. Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle alpha-actin. Neuromuscul Disord. 2004;14:461\u201370.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mus.26147","volume":"58","author":"YE Park","year":"2018","unstructured":"Park YE, Shin JH, Kim HS, Lee CH, Kim DS. Characterization of congenital myopathies at a Korean neuromuscular center. Muscle Nerve. 2018;58:235\u201344.","journal-title":"Muscle Nerve"},{"key":"1045_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1212\/WNL.0000000000001110","volume":"84","author":"I Colombo","year":"2015","unstructured":"Colombo I, Scoto M, Manzur AY, Robb SA, Maggi L, Gowda V, et al. Congenital myopathies: natural history of a large pediatric cohort. Neurology. 2015;84:28\u201335.","journal-title":"Neurology"},{"key":"1045_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/0883073812436605","volume":"27","author":"CH Wang","year":"2012","unstructured":"Wang CH, Dowling JJ, North K, Schroth MK, Sejersen T, Shapiro F, et al. Consensus statement on standard of care for congenital myopathies. J Child Neurol. 2012;27:363\u201382.","journal-title":"J Child Neurol"},{"key":"1045_CR25","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/humu.20370","volume":"27","author":"VL Lehtokari","year":"2006","unstructured":"Lehtokari VL, Pelin K, Sandbacka M, Ranta S, Donner K, Muntoni F, et al. Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Hum Mutat. 2006;27:946\u201356.","journal-title":"Hum Mutat"},{"key":"1045_CR26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3181bacf45","volume":"73","author":"NB Romero","year":"2009","unstructured":"Romero NB, Lehtokari VL, Quijano-Roy S, Monnier N, Claeys KG, Carlier RY, et al. Core-rod myopathy caused by mutations in the nebulin gene. Neurology. 2009;73:1159\u201361.","journal-title":"Neurology"},{"key":"1045_CR27","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1212\/WNL.55.11.1689","volume":"55","author":"PC Scacheri","year":"2000","unstructured":"Scacheri PC, Hoffman EP, Fratkin JD, Semino-Mora C, Senchak A, Davis MR, et al. A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology. 2000;55:1689\u201396.","journal-title":"Neurology"},{"key":"1045_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.nmd.2004.08.005","volume":"14","author":"H Jungbluth","year":"2004","unstructured":"Jungbluth H, Sewry CA, Counsell S, Allsop J, Chattopadhyay A, Mercuri E, et al. Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul Disord. 2004;14:779\u201384.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR29","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/humu.21059","volume":"30","author":"NG Laing","year":"2009","unstructured":"Laing NG, Dye DE, Wallgren-Pettersson C, Richard G, Monnier N, Lillis S, et al. Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1). Hum Mutat. 2009;30:1267\u201377.","journal-title":"Hum Mutat"},{"key":"1045_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3233\/JND-160200","volume":"4","author":"JM de Winter","year":"2017","unstructured":"de Winter JM, Ottenheijm CAC. Sarcomere dysfunction in nemaline myopathy. J Neuromuscul Dis. 2017;4:99\u2013113.","journal-title":"J Neuromuscul Dis"},{"key":"1045_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0960-8966(03)00101-9","volume":"13","author":"JC Sparrow","year":"2003","unstructured":"Sparrow JC, Nowak KJ, Durling HJ, Beggs AH, Wallgren-Pettersson C, Romero N, et al. Muscle disease caused by mutations in the skeletal muscle alpha-actin gene (ACTA1). Neuromuscul Disord. 2003;13:519\u201331.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ana.20157","volume":"56","author":"PB Agrawal","year":"2004","unstructured":"Agrawal PB, Strickland CD, Midgett C, Morales A, Newburger DE, Poulos MA, et al. Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations. Ann Neurol. 2004;56:86\u201396.","journal-title":"Ann Neurol"},{"key":"1045_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S0960-8966(97)00441-0","volume":"7","author":"HH Goebel","year":"1997","unstructured":"Goebel HH, Anderson JR, H\u00fcbner C, Oexle K, Warlo I. Congenital myopathy with excess of thin myofilaments. Neuromuscul Disord. 1997;7:160\u20138.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0960-8966(00)00167-X","volume":"11","author":"H Jungbluth","year":"2001","unstructured":"Jungbluth H, Sewry CA, Brown SC, Nowak KJ, Laing NG, Wallgren-Pettersson C, et al. Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene. Neuromuscul Disord. 2001;11:35\u201340.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR35","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/jmg.2004.020271","volume":"41","author":"AM Kaindl","year":"2004","unstructured":"Kaindl AM, R\u00fcschendorf F, Krause S, Goebel HH, Koehler K, Becker C, et al. Missense mutations of ACTA1 cause dominant congenital myopathy with cores. J Med Genet. 2004;41:842\u20138.","journal-title":"J Med Genet"},{"key":"1045_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nmd.2020.11.012","volume":"31","author":"M Garibaldi","year":"2021","unstructured":"Garibaldi M, Fattori F, Pennisi EM, Merlonghi G, Fionda L, Vanoli F, et al. Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark cores. Neuromuscul Disord. 2021;31:139\u201348.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.nmd.2010.01.011","volume":"20","author":"RM Hung","year":"2010","unstructured":"Hung RM, Yoon G, Hawkins CE, Halliday W, Biggar D, Vajsar J. Cap myopathy caused by a mutation of the skeletal alpha-actin gene ACTA1. Neuromuscul Disord. 2010;20:238\u201340.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.20260","volume":"56","author":"NG Laing","year":"2004","unstructured":"Laing NG, Clarke NF, Dye DE, Liyanage K, Walker KR, Kobayashi Y, et al. Actin mutations are one cause of congenital fibre type disproportion. Ann Neurol. 2004;56:689\u201394.","journal-title":"Ann Neurol"},{"key":"1045_CR39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.nmd.2015.02.003","volume":"25","author":"CA Sewry","year":"2015","unstructured":"Sewry CA, Holton JL, Dick DJ, Muntoni F, Hanna MG. Zebra body myopathy is caused by a mutation in the skeletal muscle actin gene (ACTA1). Neuromuscul Disord. 2015;25:388\u201391.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR40","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/mus.24353","volume":"50","author":"C Castiglioni","year":"2014","unstructured":"Castiglioni C, Cassandrini D, Fattori F, Bellacchio E, D\u2019Amico A, Alvarez K, et al. Muscle magnetic resonance imaging and histopathology in ACTA1-related congenital nemaline myopathy. Muscle Nerve. 2014;50:1011\u20136.","journal-title":"Muscle Nerve"},{"key":"1045_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.spen.2011.10.003","volume":"18","author":"S Quijano-Roy","year":"2011","unstructured":"Quijano-Roy S, Carlier RY, Fischer D. Muscle imaging in congenital myopathies. Semin Pediatr Neurol. 2011;18:221\u20139.","journal-title":"Semin Pediatr Neurol"},{"key":"1045_CR42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ana.24550","volume":"79","author":"HJ Park","year":"2016","unstructured":"Park HJ, Hong YB, Choi YC, Lee J, Kim EJ, Lee JS, et al. ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathy. Ann Neurol. 2016;79:231\u201343.","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"1045_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1042\/bj3410537","volume":"341","author":"G Lipps","year":"1999","unstructured":"Lipps G, Krauss G. Adenylosuccinate synthase from Saccharomyces cerevisiae: homologous overexpression, purification and characterization of the recombinant protein. Biochem J. 1999;341(Pt 3):537\u201343.","journal-title":"Biochem J"},{"key":"1045_CR44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.nmd.2017.02.004","volume":"27","author":"HJ Park","year":"2017","unstructured":"Park HJ, Shin HY, Kim S, Kim SH, Lee Y, Lee JH, et al. Distal myopathy with ADSSL1 mutations in Korean patients. Neuromuscul Disord. 2017;27:465\u201372.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.nmd.2020.02.006","volume":"30","author":"M Mroczek","year":"2020","unstructured":"Mroczek M, Durmus H, Bijarnia-Mahay S, T\u00f6pf A, Ghaoui R, Bryen S, et al. Expanding the disease phenotype of ADSSL1-associated myopathy in non-Korean patients. Neuromuscul Disord. 2020;30:310\u20134.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR46","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/brain\/79.4.610","volume":"79","author":"KR Magee","year":"1956","unstructured":"Magee KR, Shy GM. A new congenital non-progressive myopathy. Brain. 1956;79:610\u201321.","journal-title":"Brain"},{"key":"1045_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(60)92665-9","volume":"2","author":"V Dubowitz","year":"1960","unstructured":"Dubowitz V, Pearse AG. Oxidative enzymes and phosphorylase in central-core disease of muscle. Lancet. 1960;2:23\u20134.","journal-title":"Lancet"},{"key":"1045_CR48","first-page":"666","volume":"46","author":"AG Engel","year":"1971","unstructured":"Engel AG, Gomez MR, Groover RV. Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin Proc. 1971;46:666\u201381.","journal-title":"Mayo Clin Proc"},{"key":"1045_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nan.12369","volume":"43","author":"CA Sewry","year":"2017","unstructured":"Sewry CA, Wallgren-Pettersson C. Myopathology in congenital myopathies. Neuropathol Appl Neurobiol. 2017;43:5\u201323.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1045_CR50","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/brain\/awl077","volume":"129","author":"S Wu","year":"2006","unstructured":"Wu S, Ibarra MC, Malicdan MC, Murayama K, Ichihara Y, Kikuchi H, et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain. 2006;129:1470\u201380.","journal-title":"Brain"},{"key":"1045_CR51","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1086\/342719","volume":"71","author":"A Ferreiro","year":"2002","unstructured":"Ferreiro A, Quijano-Roy S, Pichereau C, Moghadaszadeh B, Goemans N, B\u00f6nnemann C, et al. Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet. 2002;71:739\u201349.","journal-title":"Am J Hum Genet"},{"key":"1045_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s40478-016-0392-6","volume":"4","author":"JW Witherspoon","year":"2016","unstructured":"Witherspoon JW, Meilleur KG. Review of RyR1 pathway and associated pathomechanisms. Acta Neuropathol Commun. 2016;4:121.","journal-title":"Acta Neuropathol Commun"},{"key":"1045_CR53","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1007\/s00415-018-9033-2","volume":"265","author":"JJ Todd","year":"2018","unstructured":"Todd JJ, Sagar V, Lawal TA, Allen C, Razaqyar MS, Shelton MS, et al. Correlation of phenotype with genotype and protein structure in RYR1-related disorders. J Neurol. 2018;265:2506\u201324.","journal-title":"J Neurol"},{"key":"1045_CR54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ng0993-51","volume":"5","author":"KA Quane","year":"1993","unstructured":"Quane KA, Healy JM, Keating KE, Manning BM, Couch FJ, Palmucci LM, et al. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet. 1993;5:51\u20135.","journal-title":"Nat Genet"},{"key":"1045_CR55","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/humu.22056","volume":"33","author":"A Klein","year":"2012","unstructured":"Klein A, Lillis S, Munteanu I, Scoto M, Zhou H, Quinlivan R, et al. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies. Hum Mutat. 2012;33:981\u20138.","journal-title":"Hum Mutat"},{"key":"1045_CR56","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.nmd.2011.02.015","volume":"21","author":"NF Clarke","year":"2011","unstructured":"Clarke NF. Congenital fibre type disproportion\u2014a syndrome at the crossroads of the congenital myopathies. Neuromuscul Disord. 2011;21:252\u20133.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR57","doi-asserted-by":"publisher","first-page":"E1544","DOI":"10.1002\/humu.21278","volume":"31","author":"NF Clarke","year":"2010","unstructured":"Clarke NF, Waddell LB, Cooper ST, Perry M, Smith RL, Kornberg AJ, et al. Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Hum Mutat. 2010;31:E1544\u201350.","journal-title":"Hum Mutat"},{"key":"1045_CR58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/01.wnl.0000269792.63927.86","volume":"70","author":"I Sato","year":"2008","unstructured":"Sato I, Wu S, Ibarra MC, Hayashi YK, Fujita H, Tojo M, et al. Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology. 2008;70:114\u201322.","journal-title":"Neurology"},{"key":"1045_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40478-018-0655-5","volume":"7","author":"M Garibaldi","year":"2019","unstructured":"Garibaldi M, Rendu J, Brocard J, Lacene E, Faure J, Brochier G, et al. \u2018Dusty core disease\u2019 (DuCD): expanding morphological spectrum of RYR1 recessive myopathies. Acta Neuropathol Commun. 2019;7:3.","journal-title":"Acta Neuropathol Commun"},{"key":"1045_CR60","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/jnen\/nlaa104","volume":"79","author":"M Ogasawara","year":"2020","unstructured":"Ogasawara M, Ogawa M, Nonaka I, Hayashi S, Noguchi S, Nishino I. Evaluation of the core formation process in congenital neuromuscular disease with uniform type 1 fiber and central core disease. J Neuropathol Exp Neurol. 2020;79:1370\u20135.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1045_CR61","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1111\/j.1468-1331.2008.02094.x","volume":"15","author":"M von der Hagen","year":"2008","unstructured":"von der Hagen M, Kress W, Hahn G, Brocke KS, Mitzscherling P, Huebner A, et al. Novel RYR1 missense mutation causes core rod myopathy. Eur J Neurol. 2008;15:e31\u20132.","journal-title":"Eur J Neurol"},{"key":"1045_CR62","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ana.22119","volume":"68","author":"JM Wilmshurst","year":"2010","unstructured":"Wilmshurst JM, Lillis S, Zhou H, Pillay K, Henderson H, Kress W, et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol. 2010;68:717\u201326.","journal-title":"Ann Neurol"},{"key":"1045_CR63","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.22510","volume":"70","author":"K Amburgey","year":"2011","unstructured":"Amburgey K, McNamara N, Bennett LR, McCormick ME, Acsadi G, Dowling JJ. Prevalence of congenital myopathies in a representative pediatric united states population. Ann Neurol. 2011;70:662\u20135.","journal-title":"Ann Neurol"},{"key":"1045_CR64","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0960-8966(98)00064-9","volume":"8","author":"AY Manzur","year":"1998","unstructured":"Manzur AY, Sewry CA, Ziprin J, Dubowitz V, Muntoni F. A severe clinical and pathological variant of central core disease with possible autosomal recessive inheritance. Neuromuscul Disord. 1998;8:467\u201373.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR65","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/brain\/102.3.581","volume":"102","author":"VH Patterson","year":"1979","unstructured":"Patterson VH, Hill TR, Fletcher PJ, Heron JR. Central core disease: clinical and pathological evidence of progression within a family. Brain. 1979;102:581\u201394.","journal-title":"Brain"},{"key":"1045_CR66","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0387-7604(00)00108-X","volume":"22","author":"M Tojo","year":"2000","unstructured":"Tojo M, Ozawa M, Nonaka I. Central core disease and congenital neuromuscular disease with uniform type 1 fibers in one family. Brain Dev. 2000;22:262\u20134.","journal-title":"Brain Dev"},{"key":"1045_CR67","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/archneur.1983.04050030041007","volume":"40","author":"SJ Oh","year":"1983","unstructured":"Oh SJ, Danon MJ. Nonprogressive congenital neuromuscular disease with uniform type 1 fiber. Arch Neurol. 1983;40:147\u201350.","journal-title":"Arch Neurol"},{"key":"1045_CR68","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S0960-8966(02)00135-9","volume":"12","author":"CA Sewry","year":"2002","unstructured":"Sewry CA, Muller C, Davis M, Dwyer JS, Dove J, Evans G, et al. The spectrum of pathology in central core disease. Neuromuscul Disord. 2002;12:930\u20138.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR69","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archneurol.2011.188","volume":"68","author":"A Klein","year":"2011","unstructured":"Klein A, Jungbluth H, Clement E, Lillis S, Abbs S, Munot P, et al. Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations. Arch Neurol. 2011;68:1171\u20139.","journal-title":"Arch Neurol"},{"key":"1045_CR70","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.nmd.2012.08.002","volume":"22","author":"V Straub","year":"2012","unstructured":"Straub V, Carlier PG, Mercuri E. TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI: 25-26 February 2011, Rome, Italy. Neuromuscul Disord. 2012;22:S42\u201353.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR71","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/aws036","volume":"135","author":"JJ Dowling","year":"2012","unstructured":"Dowling JJ, Arbogast S, Hur J, Nelson DD, McEvoy A, Waugh T, et al. Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. Brain. 2012;135:1115\u201327.","journal-title":"Brain"},{"key":"1045_CR72","doi-asserted-by":"publisher","first-page":"e1434","DOI":"10.1212\/WNL.0000000000008872","volume":"94","author":"JJ Todd","year":"2020","unstructured":"Todd JJ, Lawal TA, Witherspoon JW, Chrismer IC, Razaqyar MS, Punjabi M, et al. Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies. Neurology. 2020;94:e1434\u201344.","journal-title":"Neurology"},{"key":"1045_CR73","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1093\/hmg\/ddu602","volume":"24","author":"M Marino","year":"2015","unstructured":"Marino M, Stoilova T, Giorgi C, Bachi A, Cattaneo A, Auricchio A, et al. SEPN1, an endoplasmic reticulum-localized selenoprotein linked to skeletal muscle pathology, counteracts hyperoxidation by means of redox-regulating SERCA2 pump activity. Hum Mol Genet. 2015;24:1843\u201355.","journal-title":"Hum Mol Genet"},{"key":"1045_CR74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng713","volume":"29","author":"B Moghadaszadeh","year":"2001","unstructured":"Moghadaszadeh B, Petit N, Jaillard C, Brockington M, Quijano Roy S, Merlini L, et al. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet. 2001;29:17\u20138.","journal-title":"Nat Genet"},{"key":"1045_CR75","doi-asserted-by":"publisher","first-page":"e1512","DOI":"10.1212\/WNL.0000000000010327","volume":"95","author":"RN Villar-Quiles","year":"2020","unstructured":"Villar-Quiles RN, von der Hagen M, M\u00e9tay C, Gonzalez V, Donkervoort S, Bertini E, et al. The clinical, histologic, and genotypic spectrum of SEPN1-related myopathy: a case series. Neurology. 2020;95:e1512\u201327.","journal-title":"Neurology"},{"key":"1045_CR76","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1002\/acn3.51218","volume":"7","author":"A Silwal","year":"2020","unstructured":"Silwal A, Sarkozy A, Scoto M, Ridout D, Schmidt A, Laverty A, et al. Selenoprotein N-related myopathy: a retrospective natural history study to guide clinical trials. Ann Clin Transl Neurol. 2020;7:2288\u201396.","journal-title":"Ann Clin Transl Neurol"},{"key":"1045_CR77","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ana.20077","volume":"55","author":"A Ferreiro","year":"2004","unstructured":"Ferreiro A, Ceuterick-de Groote C, Marks JJ, Goemans N, Schreiber G, Hanefeld F, et al. Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol. 2004;55:676\u201386.","journal-title":"Ann Neurol"},{"key":"1045_CR78","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.20761","volume":"59","author":"NF Clarke","year":"2006","unstructured":"Clarke NF, Kidson W, Quijano-Roy S, Estournet B, Ferreiro A, Guicheney P, et al. SEPN1: associated with congenital fiber-type disproportion and insulin resistance. Ann Neurol. 2006;59:546\u201352.","journal-title":"Ann Neurol"},{"key":"1045_CR79","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ana.21846","volume":"67","author":"E Mercuri","year":"2010","unstructured":"Mercuri E, Clements E, Offiah A, Pichiecchio A, Vasco G, Bianco F, et al. Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol. 2010;67:201\u20138.","journal-title":"Ann Neurol"},{"key":"1045_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archneur.1966.00470070005001","volume":"14","author":"AJ Spiro","year":"1966","unstructured":"Spiro AJ, Shy GM, Gonatas NK. Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch Neurol. 1966;14:1\u201314.","journal-title":"Arch Neurol"},{"key":"1045_CR81","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1212\/WNL.17.8.727","volume":"17","author":"JH Sher","year":"1967","unstructured":"Sher JH, Rimalovski AB, Athanassiades TJ, Aronson SM. Familial centronuclear myopathy: a clinical and pathological study. Neurology. 1967;17:727\u201342.","journal-title":"Neurology"},{"key":"1045_CR82","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.nmd.2010.01.014","volume":"20","author":"NB Romero","year":"2010","unstructured":"Romero NB. Centronuclear myopathies: a widening concept. Neuromuscul Disord. 2010;20:223\u20138.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR83","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.nmd.2015.11.010","volume":"26","author":"K Hamanaka","year":"2016","unstructured":"Hamanaka K, Inami I, Wada T, Mitsuhashi S, Noguchi S, Hayashi YK, et al. Muscle from a 20-week-old myotubular myopathy fetus is not myotubular. Neuromuscul Disord. 2016;26:234\u20135.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR84","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ng1657","volume":"37","author":"M Bitoun","year":"2005","unstructured":"Bitoun M, Maugenre S, Jeannet PY, Lac\u00e8ne E, Ferrer X, Lafor\u00eat P, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 2005;37:1207\u20139.","journal-title":"Nat Genet"},{"key":"1045_CR85","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ng2086","volume":"39","author":"AS Nicot","year":"2007","unstructured":"Nicot AS, Toussaint A, Tosch V, Kretz C, Wallgren-Pettersson C, Iwarsson E, et al. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet. 2007;39:1134\u20139.","journal-title":"Nat Genet"},{"key":"1045_CR86","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1212\/WNL.0b013e3182a6ca62","volume":"81","author":"O Ceyhan-Birsoy","year":"2013","unstructured":"Ceyhan-Birsoy O, Agrawal PB, Hidalgo C, Schmitz-Abe K, DeChene ET, Swanson LC, et al. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology. 2013;81:1205\u201314.","journal-title":"Neurology"},{"key":"1045_CR87","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ajhg.2014.07.004","volume":"95","author":"PB Agrawal","year":"2014","unstructured":"Agrawal PB, Pierson CR, Joshi M, Liu X, Ravenscroft G, Moghadaszadeh B, et al. SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy. Am J Hum Genet. 2014;95:218\u201326.","journal-title":"Am J Hum Genet"},{"key":"1045_CR88","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.nmd.2018.06.012","volume":"28","author":"I Vandersmissen","year":"2018","unstructured":"Vandersmissen I, Biancalana V, Servais L, Dowling JJ, Vander Stichele G, Van, et al. An integrated modelling methodology for estimating the prevalence of centronuclear myopathy. Neuromuscul Disord. 2018;28:766\u201377.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR89","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/cge.14054","volume":"100","author":"SFI Reumers","year":"2021","unstructured":"Reumers SFI, Erasmus CE, Bouman K, Pennings M, Schouten M, Kusters B, et al. Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands. Clin Genet. 2021;100:692\u2013702.","journal-title":"Clin Genet"},{"key":"1045_CR90","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1212\/01.wnl.0000174625.67484.4d","volume":"65","author":"S Noguchi","year":"2005","unstructured":"Noguchi S, Fujita M, Murayama K, Kurokawa R, Nishino I. Gene expression analyses in X-linked myotubular myopathy. Neurology. 2005;65:732\u20137.","journal-title":"Neurology"},{"key":"1045_CR91","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.tcb.2006.06.001","volume":"16","author":"FL Robinson","year":"2006","unstructured":"Robinson FL, Dixon JE. Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol. 2006;16:403\u201312.","journal-title":"Trends Cell Biol"},{"key":"1045_CR92","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.molmed.2012.04.004","volume":"18","author":"K Hnia","year":"2012","unstructured":"Hnia K, Vaccari I, Bolino A, Laporte J. Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. Trends Mol Med. 2012;18:317\u201327.","journal-title":"Trends Mol Med"},{"key":"1045_CR93","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ng0696-175","volume":"13","author":"J Laporte","year":"1996","unstructured":"Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, Coy JF, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet. 1996;13:175\u201382.","journal-title":"Nat Genet"},{"key":"1045_CR94","doi-asserted-by":"crossref","unstructured":"Biancalana V, Beggs AH, Das S, Jungbluth H, Kress W, Nishino I, et al. Clinical utility gene card for: centronuclear and myotubular myopathies. Eur J Hum Genet. 2012;20.","DOI":"10.1038\/ejhg.2012.91"},{"key":"1045_CR95","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00401-017-1748-0","volume":"134","author":"V Biancalana","year":"2017","unstructured":"Biancalana V, Scheidecker S, Miguet M, Laquerri\u00e8re A, Romero NB, Stojkovic T, et al. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues. Acta Neuropathol. 2017;134:889\u2013904.","journal-title":"Acta Neuropathol"},{"key":"1045_CR96","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.nmd.2021.08.003","volume":"31","author":"MW Lawlor","year":"2021","unstructured":"Lawlor MW, Dowling JJ. X-linked myotubular myopathy. Neuromuscul Disord. 2021;31:1004\u201312.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR97","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0960-8966(02)00153-0","volume":"12","author":"M McEntagart","year":"2002","unstructured":"McEntagart M, Parsons G, Buj-Bello A, Biancalana V, Fenton I, Little M, et al. Genotype-phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord. 2002;12:939\u201346.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR98","doi-asserted-by":"publisher","first-page":"e1852","DOI":"10.1212\/WNL.0000000000007319","volume":"92","author":"M Annoussamy","year":"2019","unstructured":"Annoussamy M, Lilien C, Gidaro T, Gargaun E, Ch\u00ea V, Schara U, et al. X-linked myotubular myopathy: a prospective international natural history study. Neurology. 2019;92:e1852\u201367.","journal-title":"Neurology"},{"key":"1045_CR99","doi-asserted-by":"publisher","first-page":"e1535","DOI":"10.1212\/WNL.0000000000008316","volume":"93","author":"BT Cocanougher","year":"2019","unstructured":"Cocanougher BT, Flynn L, Yun P, Jain M, Waite M, Vasavada R, et al. Adult MTM1-related myopathy carriers: classification based on deep phenotyping. Neurology. 2019;93:e1535\u201342.","journal-title":"Neurology"},{"key":"1045_CR100","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/jnen\/nlv020","volume":"75","author":"MW Lawlor","year":"2016","unstructured":"Lawlor MW, Beggs AH, Buj-Bello A, Childers MK, Dowling JJ, James ES, et al. Skeletal muscle pathology in X-linked myotubular myopathy: review with cross-species comparisons. J Neuropathol Exp Neurol. 2016;75:102\u201310.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1045_CR101","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00401-008-0472-1","volume":"117","author":"JA Bevilacqua","year":"2009","unstructured":"Bevilacqua JA, Bitoun M, Biancalana V, Oldfors A, Stoltenburg G, Claeys KG, et al. \u201cNecklace\u201d fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy. Acta Neuropathol. 2009;117:283\u201391.","journal-title":"Acta Neuropathol"},{"key":"1045_CR102","unstructured":"Dubowitz V, Sewry CA, Oldfors A. Muscle biopsy: a practical approach. 5th edn. Saunders Elsevier, Printed in China, pp 1\u2013530. 2020."},{"key":"1045_CR103","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1172\/JCI71206","volume":"124","author":"BS Cowling","year":"2014","unstructured":"Cowling BS, Chevremont T, Prokic I, Kretz C, Ferry A, Coirault C, et al. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy. J Clin Invest. 2014;124:1350\u201363.","journal-title":"J Clin Invest"},{"key":"1045_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07057-5","volume":"9","author":"N Maani","year":"2018","unstructured":"Maani N, Sabha N, Rezai K, Ramani A, Groom L, Eltayeb N, et al. Tamoxifen therapy in a murine model of myotubular myopathy. Nat Commun. 2018;9:4849.","journal-title":"Nat Commun"},{"key":"1045_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07058-4","volume":"9","author":"E Gayi","year":"2018","unstructured":"Gayi E, Neff LA, Massana Mu\u00f1oz X, Ismail HM, Sierra M, Mercier T, et al. Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy. Nat Commun. 2018;9:4848.","journal-title":"Nat Commun"},{"key":"1045_CR106","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/humu.22067","volume":"33","author":"J B\u00f6hm","year":"2012","unstructured":"B\u00f6hm J, Biancalana V, Dechene ET, Bitoun M, Pierson CR, Schaefer E, et al. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy. Hum Mutat. 2012;33:949\u201359.","journal-title":"Hum Mutat"},{"key":"1045_CR107","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1038\/emboj.2010.249","volume":"29","author":"C Gu","year":"2010","unstructured":"Gu C, Yaddanapudi S, Weins A, Osborn T, Reiser J, Pollak M, et al. Direct dynamin-actin interactions regulate the actin cytoskeleton. Embo J. 2010;29:3593\u2013606.","journal-title":"Embo J"},{"key":"1045_CR108","doi-asserted-by":"publisher","first-page":"100077","DOI":"10.1074\/jbc.RA120.015184","volume":"296","author":"K Fujise","year":"2021","unstructured":"Fujise K, Okubo M, Abe T, Yamada H, Nishino I, Noguchi S, et al. Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy. J Biol Chem. 2021;296:100077.","journal-title":"J Biol Chem"},{"key":"1045_CR109","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1038\/emboj.2010.187","volume":"29","author":"JA Kenniston","year":"2010","unstructured":"Kenniston JA, Lemmon MA. Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients. Embo J. 2010;29:3054\u201367.","journal-title":"Embo J"},{"key":"1045_CR110","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Oca R, Cowling BS, Laporte J. Common pathogenic mechanisms in centronuclear and myotubular myopathies and latest treatment advances. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms222111377"},{"key":"1045_CR111","doi-asserted-by":"publisher","first-page":"22753","DOI":"10.1074\/jbc.C110.130013","volume":"285","author":"L Wang","year":"2010","unstructured":"Wang L, Barylko B, Byers C, Ross JA, Jameson DM, Albanesi JP. Dynamin 2 mutants linked to centronuclear myopathies form abnormally stable polymers. J Biol Chem. 2010;285:22753\u20137.","journal-title":"J Biol Chem"},{"key":"1045_CR112","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1172\/JCI74434","volume":"124","author":"AR Demonbreun","year":"2014","unstructured":"Demonbreun AR, McNally EM. Dynamin 2 the rescue for centronuclear myopathy. J Clin Invest. 2014;124:976\u20138.","journal-title":"J Clin Invest"},{"key":"1045_CR113","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/ana.21235","volume":"62","author":"M Bitoun","year":"2007","unstructured":"Bitoun M, Bevilacqua JA, Prudhon B, Maugenre S, Taratuto AL, Monges S, et al. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset. Ann Neurol. 2007;62:666\u201370.","journal-title":"Ann Neurol"},{"key":"1045_CR114","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.nmd.2012.12.009","volume":"23","author":"M Catteruccia","year":"2013","unstructured":"Catteruccia M, Fattori F, Codemo V, Ruggiero L, Maggi L, Tasca G, et al. Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort. Neuromuscul Disord. 2013;23:229\u201338.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR115","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fnagi.2014.00339","volume":"6","author":"H Jungbluth","year":"2014","unstructured":"Jungbluth H, Gautel M. Pathogenic mechanisms in centronuclear myopathies. Front Aging Neurosci. 2014;6:339.","journal-title":"Front Aging Neurosci"},{"key":"1045_CR116","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/brain\/awl071","volume":"129","author":"D Fischer","year":"2006","unstructured":"Fischer D, Herasse M, Bitoun M, Barrag\u00e1n-Campos HM, Chiras J, Lafor\u00eat P, et al. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain. 2006;129:1463\u20139.","journal-title":"Brain"},{"key":"1045_CR117","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40478-018-0593-2","volume":"6","author":"V Biancalana","year":"2018","unstructured":"Biancalana V, Romero NB, Thuestad IJ, Ignatius J, Kataja J, Gardberg M, et al. Some DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy. Acta Neuropathol Commun. 2018;6:93.","journal-title":"Acta Neuropathol Commun"},{"key":"1045_CR118","doi-asserted-by":"publisher","first-page":"11066","DOI":"10.1073\/pnas.1808170115","volume":"115","author":"S Buono","year":"2018","unstructured":"Buono S, Ross JA, Tasfaout H, Levy Y, Kretz C, Tayefeh L, et al. Reducing dynamin 2 (DNM2) rescues DNM2-related dominant centronuclear myopathy. Proc Natl Acad Sci USA. 2018;115:11066\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1045_CR119","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1212\/WNL.19.6.591","volume":"19","author":"MH Brooke","year":"1969","unstructured":"Brooke MH, Engel WK. The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children\u2019s biopsies. Neurology. 1969;19:591\u2013605.","journal-title":"Neurology"},{"key":"1045_CR120","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/jnen\/62.10.977","volume":"62","author":"NF Clarke","year":"2003","unstructured":"Clarke NF, North KN. Congenital fiber type disproportion-30 years on. J Neuropathol Exp Neurol. 2003;62:977\u201389.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1045_CR121","unstructured":"Brooke MH. Congenital fiber type disproportion. In: Kakulas BA, editor. Clinical Studies in Myology: Proceedings of the 2nd International Congress on Muscle Diseases, Perth, Australia, Nov. 22\u201329, 1971. Amsterdam: Excerpta Medica; 1973. p. 147\u201359."},{"key":"1045_CR122","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.spen.2011.10.008","volume":"18","author":"NF Clarke","year":"2011","unstructured":"Clarke NF. Congenital fiber-type disproportion. Semin Pediatr Neurol. 2011;18:264\u201371.","journal-title":"Semin Pediatr Neurol"},{"key":"1045_CR123","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/dmcn.14365","volume":"62","author":"KG Claeys","year":"2020","unstructured":"Claeys KG. Congenital myopathies: an update. Dev Med Child Neurol. 2020;62:297\u2013302.","journal-title":"Dev Med Child Neurol"},{"key":"1045_CR124","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ana.21308","volume":"63","author":"NF Clarke","year":"2008","unstructured":"Clarke NF, Kolski H, Dye DE, Lim E, Smith RL, Patel R, et al. Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol. 2008;63:329\u201337.","journal-title":"Ann Neurol"},{"key":"1045_CR125","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/humu.21157","volume":"31","author":"MW Lawlor","year":"2010","unstructured":"Lawlor MW, Dechene ET, Roumm E, Geggel AS, Moghadaszadeh B, Beggs AH. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat. 2010;31:176\u201383.","journal-title":"Hum Mutat"},{"key":"1045_CR126","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/ana.24535","volume":"78","author":"S Donkervoort","year":"2015","unstructured":"Donkervoort S, Papadaki M, de Winter JM, Neu MB, Kirschner J, Bolduc V, et al. TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype. Ann Neurol. 2015;78:982\u201394.","journal-title":"Ann Neurol"},{"key":"1045_CR127","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ng0195-75","volume":"9","author":"NG Laing","year":"1995","unstructured":"Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C, et al. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet. 1995;9:75\u20139.","journal-title":"Nat Genet"},{"key":"1045_CR128","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0960-8966(99)00053-X","volume":"9","author":"P Tan","year":"1999","unstructured":"Tan P, Briner J, Boltshauser E, Davis MR, Wilton SD, North K, et al. Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromuscul Disord. 1999;9:573\u20139.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR129","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s00415-009-5413-y","volume":"257","author":"IC Kiphuth","year":"2010","unstructured":"Kiphuth IC, Krause S, Huttner HB, Dekomien G, Struffert T, Schr\u00f6der R. Autosomal dominant nemaline myopathy caused by a novel alpha-tropomyosin 3 mutation. J Neurol. 2010;257:658\u201360.","journal-title":"J Neurol"},{"key":"1045_CR130","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nmd.2013.10.002","volume":"24","author":"T Schreckenbach","year":"2014","unstructured":"Schreckenbach T, Schr\u00f6der JM, Voit T, Abicht A, Neuen-Jacob E, Roos A, et al. Novel TPM3 mutation in a family with cap myopathy and review of the literature. Neuromuscul Disord. 2014;24:117\u201324.","journal-title":"Neuromuscul Disord"},{"key":"1045_CR131","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12929-020-00707-1","volume":"28","author":"PJ Hsu","year":"2021","unstructured":"Hsu PJ, Wang HD, Tseng YC, Pan SW, Sampurna BP, Jong YJ, et al. L-Carnitine ameliorates congenital myopathy in a tropomyosin 3 de novo mutation transgenic zebrafish. J Biomed Sci. 2021;28:8.","journal-title":"J Biomed Sci"},{"key":"1045_CR132","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/mus.25054","volume":"53","author":"T Liewluck","year":"2016","unstructured":"Liewluck T, Milone M, Tian X, Engel AG, Staff NP, Wong LJ. Adult-onset respiratory insufficiency, scoliosis, and distal joint hyperlaxity in patients with multiminicore disease due to novel Megf10 mutations. Muscle Nerve. 2016;53:984\u20138.","journal-title":"Muscle Nerve"},{"key":"1045_CR133","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s40478-019-0869-1","volume":"7","author":"HS Dafsari","year":"2019","unstructured":"Dafsari HS, Kocaturk NM, Daimag\u00fcler HS, Brunn A, D\u00f6tsch J, Weis J, et al. Bi-allelic mutations in uncoordinated mutant number-45 myosin chaperone B are a cause for congenital myopathy. Acta Neuropathol Commun. 2019;7:211.","journal-title":"Acta Neuropathol Commun"},{"key":"1045_CR134","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ajhg.2020.11.002","volume":"107","author":"S Donkervoort","year":"2020","unstructured":"Donkervoort S, Kutzner CE, Hu Y, Lornage X, Rendu J, Stojkovic T, et al. Pathogenic variants in the myosin chaperone UNC-45B cause progressive myopathy with eccentric cores. Am J Hum Genet. 2020;107:1078\u201395.","journal-title":"Am J Hum Genet"},{"key":"1045_CR135","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ajhg.2012.06.012","volume":"91","author":"K Majczenko","year":"2012","unstructured":"Majczenko K, Davidson AE, Camelo-Piragua S, Agrawal PB, Manfready RA, Li X, et al. Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores. Am J Hum Genet. 2012;91:365\u201371.","journal-title":"Am J Hum Genet"},{"key":"1045_CR136","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00401-012-1024-2","volume":"125","author":"H Tajsharghi","year":"2013","unstructured":"Tajsharghi H, Oldfors A. Myosinopathies: pathology and mechanisms. Acta Neuropathol. 2013;125:3\u201318.","journal-title":"Acta Neuropathol"},{"key":"1045_CR137","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/brain\/awm094","volume":"130","author":"C Wallgren-Pettersson","year":"2007","unstructured":"Wallgren-Pettersson C, Lehtokari VL, Kalimo H, Paetau A, Nuutinen E, Hackman P, et al. Distal myopathy caused by homozygous missense mutations in the nebulin gene. Brain. 2007;130:1465\u201376.","journal-title":"Brain"},{"key":"1045_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-25","volume":"2","author":"H Jungbluth","year":"2007","unstructured":"Jungbluth H. Central core disease. Orphanet J Rare Dis. 2007;2:25.","journal-title":"Orphanet J Rare Dis"},{"key":"1045_CR139","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0022-3476(99)70417-8","volume":"134","author":"GE Herman","year":"1999","unstructured":"Herman GE, Finegold M, Zhao W, de Gouyon B, Metzenberg A. Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr. 1999;134:206\u201314.","journal-title":"J Pediatr"},{"key":"1045_CR140","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/mus.26018","volume":"57","author":"AH Beggs","year":"2018","unstructured":"Beggs AH, Byrne BJ, De Chastonay S, Haselkorn T, Hughes I, James ES, et al. A multicenter, retrospective medical record review of X-linked myotubular myopathy: the recensus study. Muscle Nerve. 2018;57:550\u201360.","journal-title":"Muscle Nerve"},{"key":"1045_CR141","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1212\/WNL.0000000000004415","volume":"89","author":"K Amburgey","year":"2017","unstructured":"Amburgey K, Tsuchiya E, de Chastonay S, Glueck M, Alverez R, Nguyen CT, et al. A natural history study of X-linked myotubular myopathy. Neurology. 2017;89:1355\u201364.","journal-title":"Neurology"},{"key":"1045_CR142","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pediatrneurol.2016.01.023","volume":"58","author":"O Abath Neto","year":"2016","unstructured":"Abath Neto O, Silva MR, Martins Cde A, Oliveira Ade S, Reed UC, Biancalana V, et al. A study of a cohort of X-linked myotubular myopathy at the clinical, histologic, and genetic levels. Pediatr Neurol. 2016;58:107\u201312.","journal-title":"Pediatr Neurol"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01045-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01045-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01045-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:04:20Z","timestamp":1677456260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01045-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":142,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1038\/s10038-022-01045-w","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"12 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patients provided informed consent for using their samples for research after the diagnosis. This study was approved by the ethical committees of the NCNP (A2019-123).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}